FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Leucovorin Calcium Lyophilized Powder for Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Oncology; Pediatric

Please note Levoleucovorin (Fusilev) is available in ample quantities. There is potential for dosing errors when interchanging leucovorin and levoleucovorin (Fusilev). The dose of levoleucovorin (Fusilev) is one-half the dose of racemic leucovorin injection (e.g., levoleucovorin [Fusilev] 7.5 mg = racemic leucovorin 15 mg). For more information visit the Spectrum Pharmaceuticals web site.
Spectrum Pharmaceuticals

Expand all

Fresenius Kabi USA, LLC (Revised 02/21/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg SDV (NDC 63323-710-50) Backordered. Next release date anticipated March 2017. Check Wholesaler Inventory Demand increase for the drug
500 mg SDV (NDC 63323-711-00) Backordered. Next release date anticipated April 2017. Manufacturing delay

Sagent Pharmaceuticals (Revised 01/13/2017)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg vial (NDC 25021-813-10) On backorder. Estimated delivery: January 2017 Demand increase for the drug
100mg vial (NDC 25021-814-30) On backorder. Estimated delivery: January 2017 Demand increase for the drug
200mg vial (NDC 25021-815-30) On backorder. Estimated delivery: February 2017 Demand increase for the drug
350mg vial (NDC 25021-816-30) On backorder. Estimated delivery: February 2017 Demand increase for the drug

Teva Pharmaceuticals (Revised 01/04/2017)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100mg/vial, 20mL (NDC 0703-5140-01) Teva has limited inventory and product is being allocated. Limited supply on allocation is projected to be in effect until May/June 2017. Demand increase for the drug
350mg/vial 30mL (NDC 00703-5145-01) Teva has limited inventory and product is being allocated. Limited supply on allocation is projected to be in effect until May/June 2017. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English